BioSight
Companies
OPKO HEALTH, INC. logo

OPK

NASDAQMIAMI, FL
OPKO HEALTH, INC.

OPKO HEALTH develops pharmaceutical and diagnostic products, including NGENLA (Somatrogon) and Rayaldee among others. The company is engaged in research and development activities across multiple therapeutic areas, though it has a history of operating losses. OPKO is at various development and commercialization stages, with some products already on the market while continuing to invest in pipeline development.

Price history not yet available for OPK.

Pipeline

No pipeline data on record yet.

Catalyst Calendar

No catalyst events on record for yet. Check back after the next daily ingest.

Disclaimer·BioSight aggregates publicly available data (SEC EDGAR, ClinicalTrials.gov, FDA, company press releases) and is provided as is for informational purposes only. Nothing here is investment, financial, legal, tax, or medical advice, or an offer to buy or sell any security. We make no warranty as to accuracy, completeness, or timeliness; dates and filings may contain errors or be superseded without notice; past events do not predict future outcomes. To the maximum extent permitted by law, BioSight, its operators, contributors, and affiliates disclaim all liability for any loss or damage arising from use of or reliance on this site. You are solely responsible for your own investment decisions — consult a licensed professional before acting on any information.

Unlock 12-month calendar